✦ LIBER ✦

The predictive value of liver fibrosis in determining the effectiveness of interferon and lamivudine therapies for chronic hepatitis B

✍ Scribed by Michiko Shindo; Kazushige Hamada; Kenichi Nishioji; Akira Muramatsu; Yoko Oda; Tadao Okuno

Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 161 KB
Volume: 39
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-003-1293-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Importance of hepatic fibrosis in cystic

Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy

✍ Peter J. Lewindon; Ross W. Shepherd; Meagan J. Walsh; Ristan M. Greer; Richard W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB 👁 1 views

Cystic fibrosis liver disease (CFLD), which results from progressive hepatobiliary fibrosis, is an important cause of morbidity and mortality, but it is difficult to identify before portal hypertension (PHT) ensues. Clinical signs, serum alanine aminotransferase (ALT) levels, and ultrasound (US) are

The predictive value of Fibrotest vs. AP

The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C

✍ Sophie Le Calvez; Dominique Thabut; Djamila Messous; Mona Munteanu; Vlad Ratziu; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 801 KB

Wai et al. 1 developed indexes that identified significant fibrosis in patients with chronic hepatitis C. These indexes, including aspartate aminotransferase (AST) and platelets, had good discriminative power, as shown by areas under the receiver operating characteristic curve (AUROC) of 0.82 for fo

Prediction of therapy response to interf

Prediction of therapy response to interferon-alpha in chronic viral hepatitis-B by liver and hepatobiliary scintigraphy

✍ Meltem Caglar; Oktay Sari; Yusuf Akcan 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 560 KB

Combined Interferon and Lamivudine Thera

Combined Interferon and Lamivudine Therapy: Is This The Treatment of Choice for Patients With Chronic Hepatitis B Virus Infection?

✍ Norah A. Terrault 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Liver transplantation for chronic hepati

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

✍ Yoshida, Eric M. ;Erb, Siegfried R. ;Partovi, Nilufar ;Scudamore, Charles H. ;Ch 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 71 KB 👁 1 views

Current protocols for prophylaxis against allograft reinfection after liver transplantation for chronic hepatitis B virus (HBV) infection include the administration of large doses of hepatitis B immune globulin (HBIG), with considerable associated economic costs. Monotherapeutic prophylaxis with lam

Expression of transforming growth factor

Expression of transforming growth factor alpha in the liver before and after interferon alfa therapy for chronic hepatitis B

✍ Dr Yosuke Morimitsu; David E. Kleiner Jr.; Hari S. Conjeevaram; Chu Chieh Hsia; 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

The effect of interferon alfa (IFN-a) therapy on the expression of transforming growth factor alpha (TGF-a) in the liver during chronic hepatitis B was investigated. Serial liver biopsy specimens were evaluated from 35 patients who had participated in a randomized, controlled trial of recombinant hu